Healthcare Triangle, Inc. (HCTI)
NASDAQ: HCTI · Real-Time Price · USD
1.860
-0.230 (-11.00%)
At close: Nov 17, 2025, 4:00 PM EST
1.820
-0.040 (-2.15%)
After-hours: Nov 17, 2025, 4:51 PM EST

Healthcare Triangle Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Healthcare Triangle in the last 12 months.

Price Target: n/a
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Healthcare Triangle.

Recommendation Trends

RatingJul '22Aug '22Sep '22
Strong Buy110
Buy000
Hold000
Sell000
Strong Sell000
Total110

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
EF Hutton
EF Hutton
Strong Buy
Maintains
$9,960$4,980
Strong BuyMaintains$9,960$4,980+267,641.94%Sep 28, 2022
EF Hutton
EF Hutton
Strong Buy
Initiates
$9,960
Strong BuyInitiates$9,960+535,383.87%Mar 14, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
19.60M
from 11.70M
Increased by 67.59%
Revenue Next Year
28.45M
from 19.60M
Increased by 45.16%
EPS This Year
-1.40
from -281.58
EPS Next Year
-0.26
from -1.40
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
31.34M35.27M45.89M33.20M11.70M19.60M28.45M
Revenue Growth
9.06%12.54%30.10%-27.64%-64.77%67.59%45.16%
EPS
209.16-503.34-966.61-517.52-281.58-1.40-0.26
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272028
High20.2M29.3M
Avg19.6M28.5M
Low18.8M27.3M

Revenue Growth

Revenue Growth2025202620272028
High
72.5%
49.4%
Avg
67.6%
45.2%
Low
61.0%
39.5%

EPS Forecast

EPS2025202620272028
High-1.44-0.26
Avg-1.40-0.26
Low-1.34-0.25

EPS Growth

EPS Growth2025202620272028
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.